Posts tagged Sarah Roden


Analysts Have Mixed Ratings After Intel Corporation Posts Flat Quarterly Report (INTC)

Intel Corporation (NASDAQ:INTC) released first quarter earnings on April 14 in-line with revised guidance. On …

Read more

Analysts Positive on Amazon.com, Inc. Considering Expanded Offerings and Services (AMZN)

Amazon.com, Inc. (NASDAQ:AMZN) is expanding in more ways than one. The online marketplace is continuously …

Read more

Increasing the Minimum Wage, One CEO at a Time (MCD) (WMT) (SBUX)

Since fast food workers began protesting low salaries last year, minimum wage has come under …

Read more

J.P. Morgan’s 3 Biotechnology Picks: bluebird bio Inc (BLUE), BioMarin Pharmaceutical Inc. (BMRN), Clovis Oncology Inc (CLVS)

Following the annual J.P. Morgan Biotech Napa Forum, analyst Cory Kasimov offered commentary on a handful on …

Read more

Analysts Weigh in on General Electric Company Following Drastic Restructuring (GE)

On April 10, General Electric Company (NYSE:GE) announced bold restructuring plans to sell most of …

Read more

Analysts Weigh In Following Gap Inc’s Mixed March Sales Report

Gap Inc (NYSE:GPS) announced March sales on April 9. Although Gap stated that net sales …

Read more

Mixed Ratings on Teva Pharmaceuticals Industries Ltd (ADR) Following Merge with Auspex Pharmaceuticals Inc

On March 30, Teva Pharmaceuticals Industries Ltd (ADR) (NYSE:TEVA) announced they will be acquiring Auspex …

Read more

Analysts Weigh in Lululemon Athletica Inc. Following Meeting with New CFO

Analysts recently met with Lululemon Athletica Inc.’s (NASDAQ:LULU) new CFO, Stuart Haselden, to discuss the …

Read more

Cowen & Co and S&P Capital are Positive on FedEx Corporation’s Acquisition of TNT Express

On April 7, FedEx Corporation (NYSE:FDX) announced a deal to buy Dutch delivery firm TNT …

Read more

Prescription Data Offers Insight Into Gilead Sciences, Inc. Sales

Gilead Sciences, Inc. (NASDAQ:GILD) received new data from IMS Health about the breakdown of its …

Read more